Agent for pamping

Many people who professionally go in for bodybuilding or just fans don't think of the trainings without so-called fullness of a blood of muscles or pamping. Carrying out a huge number of approaches and repetitions not it turns out to achieve that rating about which the great athlete of all times and the people Arnold Schwarzenegger spoke from everyone. But not everything is as difficult as can seem. For today in drugstores of Russia it is possible with ease and without prescription to buy not banned drug which is named Agapurin. Also names Trental or Pentoxifylline are possible. This drug in tablets is produced. Usually in one packing of 60 tablets on 100 mg. On average, drug cost slightly exceeds 100 rubles for packing. Also exists it is long the current version Agapurin Retard in tablets on 400 mg.

Agapurin is high active agent which dilates blood vessels, as a result there is an intensifying of a blood flow and improvement of microcirculation in muscular tissue, viscosity of a blood decreases. Those who tried Agapurin during the trainings, told about the feeling of the strongest rating sometimes surpassing in the force feelings from use of such drugs which is breaking off muscles as Enanatat and Tsipionat (Aethers of men's hormone of Testosteron-Depotum). Stronger feelings can achieve if to combine Agapurin with Aspirin and RR vitamin. These drugs in bodybuilding for development of capillary network in muscles which is absolutely necessary for pamping and body height of muscles are used.

Course. In practice, Agapurin is used according to the following scheme: day of training – 2 tablets after food three times a day, day of rest – 1 tablet after food three times a day. After three weeks of reception according to this scheme of Agapurin it is necessary to take a break lasting a month. Just during this break it is necessary to return to the ordinary trainings to approach a new stage of pamping with the increased working balances.

AGAPURIN (Pentoxifylline)

structure and release form

Active ingredient is oentocsifillin.

1 ml of solution for injections contains Pentoxifylline of 20 mg; in ampoules on 5 ml, in a box - 5 pieces.

1 dragees - 100 mg; in vials of dark glass - 60 pieces.

Pharmacokinetics

It is soaked up quickly, from the prolonged form it is released slowly, the maximum concentration is defined in 2 hours after reception (in 12 hours decreases to 25%). It is distributed evenly, removed by kidneys (about 94%) and an intestine (about 4%) in the form of metabolites (only about 2% - in not changed look); in the first 4 hours about 90% of a dose is removed.

Indications to use

• Disturbances of periphery circulation during an exercise stress.
• Trophic disturbances (varicose ulcers, frostbites, etc.).
• Angioneyropatiya (paresthesia, Crocq's disease).
• Disturbances of cerebral circulation (atherosclerosis), acute and chronic failure of blood supply of a mesh and vascular cover of an eye; acute functional disorders of an inner ear.

Contraindications

Acute myocardial infarction, massive bleeding, cerebral hemorrhages.

Side effects

Dyspeptic phenomena, giddiness, feeling of fever, itch, urticaria.

Interaction

Synergy with antihypertensive (sympatholytics, ganglioblokator, vazodilatator, etc.).

Route of administration and doses

Inside, after food, without chewing, washing down with a small amount of liquid, 2 dragees 3 times a day within 1 week; at sharp dropping of the ABP the dose is reduced to 1 dragee by 3 times a day, the same doses apply at a long course of treatment.

V/v (struyno or by drop infusion), intravenously (struyno or by drop infusion), intramuscularly. The dose and the scheme of treatment are established individually.

Precautionary measures

It is necessary to apply under control of the ABP: at hypotension and lability of a circulation sharp hypotension and an attack of stenocardia can develop. At a heart failure administration of cardiac glycosides is necessary. At the patients with a diabetes mellitus accepting hypoglycemic agents, purpose of high doses of Agapurin can cause the expressed hypoglycemia therefore doses of hypoglycemic agents have to be corrected.